Seer Inc
NASDAQ:SEER

Watchlist Manager
Seer Inc Logo
Seer Inc
NASDAQ:SEER
Watchlist
Price: 2.21 USD -1.78%
Market Cap: 130.3m USD
Have any thoughts about
Seer Inc?
Write Note

Seer Inc
Other Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Seer Inc
Other Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Seer Inc
NASDAQ:SEER
Other Liabilities
$26.1m
CAGR 3-Years
116%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Other Liabilities
$4.3B
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
15%
Danaher Corp
NYSE:DHR
Other Liabilities
$5.6B
CAGR 3-Years
-12%
CAGR 5-Years
-1%
CAGR 10-Years
3%
Mettler-Toledo International Inc
NYSE:MTD
Other Liabilities
$289.8m
CAGR 3-Years
-7%
CAGR 5-Years
-5%
CAGR 10-Years
5%
Agilent Technologies Inc
NYSE:A
Other Liabilities
$708m
CAGR 3-Years
-7%
CAGR 5-Years
-3%
CAGR 10-Years
-11%
IQVIA Holdings Inc
NYSE:IQV
Other Liabilities
$800m
CAGR 3-Years
-7%
CAGR 5-Years
-1%
CAGR 10-Years
17%
No Stocks Found

Seer Inc
Glance View

Market Cap
131.7m USD
Industry
Life Sciences Tools & Services

Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. The company is headquartered in Redwood City, California and currently employs 118 full-time employees. The company went IPO on 2020-12-04. The firm enables scientific outcomes by commercializing products for researchers to unlock biological information. Its initial product, the Proteograph Product Suite (Proteograph), uses its engineered nanoparticle (NP) technology to provide access across the proteome. Its Proteograph Product Suite is comprised of consumables, an automation instrument and software. Its Proteograph provides a workflow, which enables proteomic profiling and the analysis of samples needed to characterize the nature of the proteome. The Company’s Proteograph consumables consist of its NP panel and other consumables necessary to assay samples on its SP100 automation instrument. Its SP100 automation instrument is custom-configured liquid handling workstation. The firm's Proteograph Instrument Control Software (PICS) for the SP100 instrument is fixed and designed to its specified workflow.

SEER Intrinsic Value
3.19 USD
Undervaluation 31%
Intrinsic Value
Price

See Also

What is Seer Inc's Other Liabilities?
Other Liabilities
26.1m USD

Based on the financial report for Dec 31, 2023, Seer Inc's Other Liabilities amounts to 26.1m USD.

What is Seer Inc's Other Liabilities growth rate?
Other Liabilities CAGR 3Y
116%

Over the last year, the Other Liabilities growth was -8%. The average annual Other Liabilities growth rates for Seer Inc have been 116% over the past three years .

Back to Top